These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 12132349

  • 21. The role of C-peptide in the classification of diabetes mellitus.
    Wright-Pascoe R, Mills J, Choo-Kang E, Morrison EY.
    West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
    [Abstract] [Full Text] [Related]

  • 22. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E, Sabuncu T, Ozer EM, Hatemi H.
    J Diabetes Complications; 2005 Jun; 19(5):254-8. PubMed ID: 16112499
    [Abstract] [Full Text] [Related]

  • 23. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.
    Faresjö MK, Vaarala O, Thuswaldner S, Ilonen J, Hinkkanen A, Ludvigsson J.
    Diabetes Metab Res Rev; 2006 Jun; 22(6):462-70. PubMed ID: 16572494
    [Abstract] [Full Text] [Related]

  • 24. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
    Huang YY, Huang P, Lou HL.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
    [Abstract] [Full Text] [Related]

  • 25. [Prognostic value of humoral and metabolic markers as an evaluation of risk for developing type 1 diabetes].
    Młynarski W, Wyka K, Bodalska-ŁIpińska J, Andrzejewski W, Zmysłowska A, Bodalski J.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003 Aug; 9(1):17-22. PubMed ID: 12831633
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G, Auinger M, Clodi M, Prischl F, Kramar R, Diabetic Nephropathy Study Group of the Austrian Society of Nephrology.
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [Abstract] [Full Text] [Related]

  • 27. C-peptide and autoimmune markers in diabetes.
    Törn C.
    Clin Lab; 2003 Mar; 49(1-2):1-10. PubMed ID: 12593469
    [Abstract] [Full Text] [Related]

  • 28. Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration.
    Lindström T, Frystyk J, Hedman CA, Flyvbjerg A, Arnqvist HJ.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):776-82. PubMed ID: 17121530
    [Abstract] [Full Text] [Related]

  • 29. [Clinical value of C-peptide determination].
    Meier C, Ladewig A, Keller U, Berger W.
    Praxis (Bern 1994); 1997 Aug 20; 86(34):1289-95. PubMed ID: 9381016
    [Abstract] [Full Text] [Related]

  • 30. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
    Mallone R, Ortolan E, Pinach S, Volante M, Zanone MM, Bruno G, Baj G, Lohmann T, Cavallo-Perin P, Malavasi F.
    Diabetologia; 2002 Dec 20; 45(12):1667-77. PubMed ID: 12488956
    [Abstract] [Full Text] [Related]

  • 31. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X, Yang L, Zhou Z, Huang G, Yan X.
    Chin Med J (Engl); 2003 Nov 20; 116(11):1728-32. PubMed ID: 14642146
    [Abstract] [Full Text] [Related]

  • 32. Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.
    Bodansky HJ, Medbak S, Drury PL, Cudworth AG.
    Diabete Metab; 1981 Dec 20; 7(4):265-9. PubMed ID: 7333406
    [Abstract] [Full Text] [Related]

  • 33. Does glucagon stimulation test help to predict autoimmunity in newly diagnosed non obese adults with diabetes?
    Rogowicz-Frontczak A, Zozulińska-Ziółkiewicz D, Niedźwiecki P, Litwinowicz M, Wierusz-Wysocka B.
    Exp Clin Endocrinol Diabetes; 2012 Jul 20; 120(7):428-34. PubMed ID: 22549345
    [Abstract] [Full Text] [Related]

  • 34. [Personal experience with determination of NT-proBNP in clinical practice].
    Stejskal D, Oral I, Lacnák B, Juráková R, Horalík D, Adamovská S, Prosková J, Hrabovská I, Ozanová G.
    Vnitr Lek; 2003 Feb 20; 49(2):121-6. PubMed ID: 12728579
    [Abstract] [Full Text] [Related]

  • 35. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
    Betterle C, Lazzarotto F, Fusari A, Zanchetta R, Benedini S, Pedini B, Moscon A, Presotto F.
    Acta Diabetol; 2006 Nov 20; 43(3):79-83. PubMed ID: 17143785
    [Abstract] [Full Text] [Related]

  • 36. [Diabetes mellitus, but which type?].
    Hoekstra JB, de Koning EJ.
    Ned Tijdschr Geneeskd; 2004 Apr 17; 148(16):761-4. PubMed ID: 15129562
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.